[1] Kuniyoshi Y, Koja K, Miyagi K, et al. Prevention of postoperative paraplegia during thoracoabdominal aortic surgery. Ann Thorac Surg. 2003; 76(5): 1477-1484.
[2] Dppolito G, Diabriras S, Howard GA, et al. Low oxygentension inhibits osteogenic differentiation and enhances stermness of human MIAMI cell. Bone. 2006; 39(3): 513-522.
[3] Nishimura R, Okuda K. Hypoxia is important for establishing vascularization during corpus luteum formation in cattle. J Reprod Dev. 2010; 56(1): 110-116.
[4] Giatromanolaki A, Fiska A, Pitsiava D, et al. Erythropoietin receptors in endometrial carcinoma as related to HIF1{alpha} and VEGF expression. In Vivo. 2009; 23(5): 699-703.
[5] Seregin SS, Amalfitano A. Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors. Expert Opin Biol Ther. 2009; 9(12): 1521-1531.
[6] Fiorenzo P, Mongiardi MP, Dimitri D, et al. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo. Int J Oncol. 2010; 36(4): 785-791.
[7] Wan C, Gilbert SR, Wang Y, et al. Activation of the hypoxia-inducible factor-1-alpha pathway accelerates. Proc Nat Acad Sci. 2008; 105(2): 686-691.
[8] Giaccia A , Siim BG , Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Discov. 2003; 2(10): 803-811.
[9] Khan TA , Sellke FW , Laham RJ. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia. Gene Ther. 2003; 10(4): 285-291.
[10] Semenza GL. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today. 2007; 12(19-20): 853-859.
[11] Bruick RK , McKnight SL. A conserved family of prolyl- 4- hydroxylases that modify HIF. Science. 2001; 294(5545): 1337-1340.
[12] Evans CE, Humphries J, Mattock K, et al. Hypoxia and upregulation of hypoxia- inducible factor 1{alpha} stimulate venous thrombus recanalization. Arterioscler Thromb Vasc Biol. 2010; 30(12): 2443-2451.
[13] Lando D, Peet DJ, Whelan DA, et al. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. 2002; 295(5556): 858-861.
[14] Zhang Z, Wang G, Li C, et al. Construction and characterization of a recombinant human adenovirus vector expressing bone morphogenetic protein 2. Exp Ther Med. 2013; 6(2):329-334.
[15] Liu D, Hu L, Zhang Z, et al. Construction of human BMP2-IRES-HIF1αmu adenovirus expression vector and its expression in mesenchymal stem cells. Mol Med Rep. 2013; 7(2):659-663.
[16] Emans PJ , Spaapen F , Surtel DA , et al. A novel in vivo model to study endochondral bone formation;HIF-1α activation and BMP expression. Bone。 2007; 40(2): 409-418.
[17] Lim W, Cho J, Kwon HY, et al. Hypoxia-inducible factor 1 alpha activates and is inhibited by unoccupied estrogen receptor beta. FEBS Lett. 2009; 583(8): 1314-1318.
[18] Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999; 286(5449):2511-2514.
[19] Visconti RP, Richardson CD, Sato TN. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl A cad Sci USA.2002; 99(12):8219-8224.
[20] 朱国强,吴织芬,王勤涛,等. IGF-1对骨髓基质细胞分泌BMP-2和VEGF的影响[J].临床口腔医学杂志,2004, 20(4):215-217.
[21] 郜勇,杨述华,杨操,等.人血管内皮细胞生长因子重组腺病毒载体的构建、鉴定及在骨髓间充质干细胞的表达[J].中华实验外科杂志,2006,23(2):138-140.
[22] Fam NP, Verma S, Kutryk M, et al. Clinician guide to angiogenesis. Circulation. 2003; 108(21):2613-2618.
[23] Bruick RK, McKnight SL. Building better vasculature. Genes Dev. 2001; 15(19): 2497-2502.
[24] Semenza GL . HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol. 2000; 88(4):1474-1480.
[25] Rebours V, Albuquerque M, Sauvanet A, et al. Hypoxia pathways and cellular stress activate pancreatic stellate cells: development of an organotypic culture model of thick slices of normal human pancreas. PLoS One. 2013; 8(9): e76229.
[26] Cury V, Moretti AI, Assis L, et al. Low level laser therapy increases angiogenesis in a model of ischemic skin flap in rats mediated by VEGF, HIF-1α and MMP-2. J Photochem Photobiol B. 2013; 125: 164-170.
[27] Pawlus MR, Hu CJ. Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response. Cell Signal. 2013; 25(9): 1895-1903.
[28] Ding G, Liu HD, Liang HX, et al. HIF1-regulated ATRIP expression is required for hypoxia induced ATR activation. FEBS Lett. 2013; 587(7): 930-935.
[29] Tong Y, Li QG, Xing TY, et al. HIF1 regulates WSB-1 expression to promote hypoxia-induced chemoresistance in hepatocellular carcinoma cells. FEBS Lett. 2013; 587(16): 2530-2535.
[30] Wu WJ, Zhang XK, Zheng XF, et al. SHH-dependent knockout of HIF-1 alpha accelerates the degenerative process in mouse intervertebral disc. Int J Immunopathol Pharmacol. 2013; 26(3): 601-609.
[31] Huang C, Hales BF. Effects of exposure to a DNA damaging agent on the hypoxia inducible factors in organogenesis stage mouse limbs. PLoS One. 2012; 7(12): e51937.
[32] Zimmermann SM, Würgler-Hauri CC, Wanner GA, et al. Echinomycin in the prevention of heterotopic ossification - an experimental antibiotic agent shows promising results in a murine model. Injury. 2013; 44(4):570-575.
[33] Huang SM, Chen TS, Chiu CM, et al. GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interaction. Endocr Relat Cancer. 2013; 21(1): 73-84.
[34] Steunou AL, Ducoux-Petit M, Lazar I, et al. Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development. Mol Cell Proteomics. 2013; 12(3): 736-748.
[35] Maher ER. HIF2 and endocrine neoplasia: an evolving story. Endocr Relat Cancer. 2013; 20(3): C5-7.
[36] Bensellam M, Duvillié B, Rybachuk G, et al. Glucose-induced O? consumption activates hypoxia inducible factors 1 and 2 in rat insulin-secreting pancreatic beta-cells. PLoS One. 2012; 7(1): e29807.
[37] Lange C, Caprara C, Tanimoto N, et al. Retina-specific activation of a sustained hypoxia-like response leads to severe retinal degeneration and loss of vision. Neurobiol Dis. 2011; 41(1):119-130.
[38] Pawlus MR, Wang L, Ware K, et al. Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia. Mol Cell Biol. 2012; 32(22): 4595-4610.
[39] Aragonés J, Elorza A, Acosta-Iborra B, et al. Myeloid hypoxia-inducible factors in inflammatory diseases. Crit Rev Immunol. 2011; 31(1): 1-13.
[40] Simon F, Bockhorn M, Praha C, et al. Deregulation of HIF1-alpha and hypoxia- regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue--influence of a modulated host stroma on the prognosis of HCC. Langenbecks Arch Surg. 2010; 395(4): 395-405.
[41] Wu XQ, Huang C, He X, et al. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer. Cell Signal. 2013; 25(12): 2462-2468.
[42] Coudyzer P, Lemoine P, Jordan BF, et al. Hypoxia is not required for human endometrial breakdown or repair in a xenograft model of menstruation. FASEB J. 2013; 27(9): 3711-3719.
[43] Sena JA, Wang L, Hu CJ. BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes. Mol Cell Biol. 2013; 33(19): 3849-3863.
[44] Shen G, Li X, Jia YF, et al. Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin. 2013; 34(3): 336-341.
[45] Lin J, Qin X, Zhu Z, et al. FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β. IUBMB Life. 2012; 64(11): 921-930.
[46] Minervini G, Masiero A, Moro S, et al. In silico investigation of PHD-3 specific HIF1-α proline 567 hydroxylation: a new player in the VHL/HIF-1α interaction pathway? FEBS Lett. 2013; 587(18):2996-3001.
[47] Green L, Cookson A, Bruce IN, et al. Identification of multiple, oxygen-stable HIF1 alpha isoforms, and augmented expression of adrenomedullin in rheumatoid arthritis. Clin Exp Rheumatol. 2013; 31(5):672-682.
[48] Elson DA , Thurston G , Huang LE , et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 2001; 15(19): 2520-2532.
[49] Li C, Liu D, Zhang Z, et al. Triple point-mutants of hypoxia-inducible factor-1α accelerate in vivo angiogenesis in bone defect regions. Cell Biochem Biophys. 2013; 67(2): 557-566. |